Predictive role of HER-2/neu overexpression and clinical features at initial presentation in patients with extensive stage small cell lung carcinoma
- 1 June 2002
- journal article
- Published by Elsevier in Lung Cancer
- Vol. 36 (3) , 257-261
- https://doi.org/10.1016/s0169-5002(01)00488-3
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Lung cancerThe Lancet, 2000
- Outcome of Patients With Small-Cell Lung Cancer During 20 Years of Clinical Research at the US National Cancer InstituteMayo Clinic Proceedings, 1997
- HER-2/neu Expression in Pancreatic AdenocarcinomaPancreas, 1997
- The expression of p185(HER-2/neu) correlates with the stage of disease and survival in colorectal cancerGastroenterology, 1997
- Immunocytochemical expression of tissue specific transcription factor-1 in lung carcinoma.Journal of Clinical Pathology, 1997
- Epidermal growth factor receptor and c-erbB-2 oncoprotein expression in female genital tract carcinosarcomas (Malignant mixed müllerian tumors): Clinicopathologic study of 82 casesCancer, 1996
- Cancer statistics, 1996CA: A Cancer Journal for Clinicians, 1996
- c-erbB-2 Oncoprotein Overexpression in Uterine Cervix Carcinoma With Glandular Differentiation:A Frequent Event But Not an Independent Prognostic Marker Because It Occurs Late in the DiseaseAmerican Journal of Clinical Pathology, 1995
- Risk of kidney cancer and other second solid malignancies in patients with chronic lymphocytic leukemiaEuropean Journal of Haematology, 1994
- Cancer statistics, 1994CA: A Cancer Journal for Clinicians, 1994